Skip to main content
logo
Uwell Biopharma, Inc. (TPEX:7902)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.90
-0.05 (-0.14%)
At close: Sep 7, 2026

Uwell Biopharma Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.040.040.45---
Revenue Growth
0%-92.22%----
Gross Profit
0.030.030.3---
Operating Income
-75.76-68.39-43.42-48.64-50.03-49.64
Net Income
-71.61-66.2-40.87-45.17-41.47-49.99
Earnings Per Share
-0.37-0.43-0.35-0.51-0.73-2.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
285.27320.2447.986.0927.7167.76
Total Debt
11.894.265.118.128.3412.53
Net Cash (Debt)
273.37315.9842.7977.9819.3755.23
Net Cash Growth
-13.48%638.50%-45.13%302.67%-64.94%188.23%
Net Cash Per Share
1.402.060.370.880.342.34

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-58.62-52.31-32.38-40.63-35.24-42.64
Capital Expenditures
-6-2.05--2.01-0.62-1
Free Cash Flow
-64.62-54.36-32.38-42.64-35.86-43.65
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
80.00%80.00%66.89%---
Operating Margin
-216445.71%-195391.43%-9648.00%---
Pretax Margin
-204605.71%-189137.14%-9082.67%---
Profit Margin
-204605.71%-189137.14%-9082.67%---
FCF Margin
-184634.29%-155300.00%-7196.22%---